首都医科大学附属北京友谊医院，是一家三级甲等医院，是首都医科大学附属第二临床医学院。医院设有西城院区和通州院区并计划建设顺义院区，西城院区位于首都核心区，通州院区位于城市副中心。

During the past decade, Beijing Friendship Hospital, Capital Medical University conducted 264 clinical trials. In the 10-year time frame, 264 clinical trials started and 34 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 141 clinical trials started and 29 clinical trials were completed. i.e. 20.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Friendship Hospital, Capital Medical University" #1 sponsor was "Beijing Friendship Hospital" with 87 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Nanfang Hospital of Southern Medical University" with 11 trials sponsored, "BeiGene" with 10 trials sponsored and "Janssen Research & Development, LLC" with 10 trials sponsored. Other sponsors include 175 different institutions and companies that sponsored additional 114 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Friendship Hospital, Capital Medical University" #1 collaborator was "Beijing Friendship Hospital" with 16 trials as a collaborator, "Peking Union Medical College Hospital" with 13 trials as a collaborator, "Peking University People's Hospital" with 12 trials as a collaborator, "Beijing Hospital" with 8 trials as a collaborator and "Beijing Tiantan Hospital" with 8 trials as a collaborator. Other collaborators include 385 different institutions and companies that were collaborators in the rest 224 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Friendship Hospital, Capital Medical University" are "Hemophagocytic Lymphohistiocytosis" (12 trials), "Chronic Hepatitis B" (7 trials), "Liver Cirrhosis" (7 trials), "Hypertension" (6 trials) and "Crohn Disease" (5 trials). Many other conditions were trialed in "Beijing Friendship Hospital, Capital Medical University" in a lesser frequency.

Most popular intervention types in "Beijing Friendship Hospital, Capital Medical University" are "Drug" (202 trials), "Other" (29 trials), "Device" (26 trials), "Procedure" (26 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Tislelizumab" (7 trials), "Atezolizumab" (6 trials), "Cisplatin" (5 trials) and "Lansoprazole" (5 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Friendship Hospital, Capital Medical University" are 291 trials for "All" genders, 10 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are 133 active trials in "Beijing Friendship Hospital, Capital Medical University". 10 are not yet recruiting, 85 are recruiting, 34 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 100 completed trials in Beijing Friendship Hospital, Capital Medical University, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Friendship Hospital, Capital Medical University, 18 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 53 trials that are defined as “Not Applicable".